Keyword: Harvard University
A tool called “polygenic risk scoring” could help physicians identify who faces a high risk of serious diseases.
One of the founding scientists of Illumina has come out with a new gene-sequencing software startup that aims to tackle antimicrobial resistance.
New discoveries in biotech include a coated capsule for delivering insulin and inherited gene mutations that may portend pancreatic cancer risk.
Feng Zhang's latest CRISPR company, Beam Therapeutics, officially came out of stealth Monday with $87 million in series A funding.
The past week ushered in news of a drug that reverses the decline of intestinal stem cells, a CAR-T for colorectal cancer and more.
The Sino-American startup thinks it can detect cell-free DNA in blood plasma and thereby enable screening for early-stage disease.
Amgen joined with MP Healthcare Venture Management and Alexandria Venture Investments to put the latest tranche of funding into QurAlis.
Novartis foresees next-generation immunotherapies that use biodegradable implants and injectable systems to trigger long-lasting attacks on tumors.
A Harvard-led research team has identified a brain protein that exacerbates memory loss with age or PTSD.
Inscripta offers its CRISPR enzymes for free, but the biotech plans to make its money selling CRISPR tools.